下一代医学：人工智能和机器学习（英文版）

www.tmcapital.com/healthcareTheNextGenerationofMedicine:ArtificialIntelligenceandMachineLearningTMCapitalIndustrySpotlightwww.tmcapital.com/healthcareCaseStudy:GrowthEquityCapitalRaiseAnalytics4Liferaised$25.6millionthroughthesaleofSeriesBConvertiblePreferredStockAnalytics4Life,aToronto-baseddeveloperofartificialintelligence-enabledmedicalimagingsolutions,hasraised$25.6millionthroughthesaleofSeriesBConvertiblePreferredStock.Analytics4Life,ledbyformerSapheon,Inc.CEODonCrawford,isfocusedonusingartificialintelligencetoimprove,simplifyandreducethecostofdiagnosingcoronaryarterydisease(“CAD”),a$6billionglobalmarket.TheCompany’snon-invasivemedicaldevice,CorVista?,appliesmachinelearnedsolutionstoassessthepresenceofsignificantCAD,usingphysiologicalsignalsnaturallyemittedby